REG - Competition and Mkts - Merger Update: Stryker / Cerus

StrykerAnnouncement

23/02/2023 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230223:nRSW7080Qa&default-theme=true

RNS Number : 7080Q  Competition and Markets Authority  23 February 2023

 

START OF CMA MERGER INVESTIGATION: ANTICIPATED ACQUISITION BY STRYKER
CORPORATION OF CERUS ENDOVASCULAR LIMITED

 

The Competition and Markets Authority (CMA) is considering whether it is or
may be the case that this transaction, if carried into effect, will result in
the creation of a relevant merger situation under the merger provisions of the
Enterprise Act 2002 and, if so, whether the creation of that situation may be
expected to result in a substantial lessening of competition within any market
or markets in the United Kingdom for goods or services.

 

The CMA announced the launch of its merger inquiry by notice to the Parties on
23 February 2023 and has a deadline of 24 April 2023 for its Phase 1 decision.

 

Invitation to comment: closes 9 March 2023

 

To assist it with this assessment, the CMA invites comments on the transaction
from any interested party.

 

These comments should be provided by the deadline set out above to:

 

Georgia Zele

georgia.zele@cma.gov.uk (mailto:georgia.zele@cma.gov.uk)

 

Gulalay Hammad

gulalay.hammad@cma.gov.uk (mailto:gulalay.hammad@cma.gov.uk)

 

 

Your name and contact details are your personal data. In collecting,
receiving, storing, accessing and using your personal data, the CMA, as
controller, is processing your personal data. The CMA processes personal data
in accordance with data protection law. The CMA is processing your personal
data so that it can contact you again, should it need further help or
information from you, in order to carry out its merger work under Part 3 of
the Enterprise Act 2002. For more information about how the CMA processes
personal data and your rights relating to that data, please see our Privacy
Notice
(https://www.gov.uk/government/organisations/competition-and-markets-authority/about/personal-information-charter)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERTTMLTMTTTMMJ